Procter & Gamble Health · NSE: PGHL · BSE: 500126
Q1 FY27 results · Apr–Jun 2026
Procter & Gamble Health reported revenue from operations of ₹363.71 crore (up 7.4% from Q1 FY26) and net profit of ₹96.15 crore (up 45.3% from Q1 FY26) for Q1 FY27 (Apr–Jun 2026), on a standalone basis.
| Item | Q1 FY27 | Q1 FY26 | YoY | Q4 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 363.71 | 338.74 | +7.4% | 370.45 | −1.8% |
| Other income | 3.88 | 4.03 | −3.7% | 4.00 | −3.0% |
| Total income | 367.59 | 342.77 | +7.2% | 374.45 | −1.8% |
| Profit before tax | 129.12 | 88.81 | +45.4% | 133.21 | −3.1% |
| Net profit for the period | 96.15 | 66.18 | +45.3% | 94.60 | +1.6% |
| EPS, basic (₹) | 57.92 | 39.87 | +45.3% | 56.99 | +1.6% |
| Net margin (%) | 26.4 | 19.5 | 25.5 |
Standalone
- Filed with BSE
- 06 Aug 2026, 18:14 IST
- Board meeting
- 06 Aug 2026
- Period
- 01 Apr 2026 to 30 Jun 2026
- Review status
- Unaudited
- Source
- XBRL filing on BSE